Top news
Experimental COVID-19 vaccine safe, generates immune response
Moderna shares jump as much as 16% after company says its coronavirus vaccine trial produced 'robust' immune ...
By Berkeley Lovelace & Berkeley Lovelace Jr.
Moderna Stock Rallies, Briefly, On Cancer Vaccine News — Is It A Buy?
By Allison Gatlin
China's Sinopharm launches Phase III trial of Covid-19 vaccine in UAE
By Divya Tirumalaraju
All coverage
Oxford’s Covid-19 Vaccine Is the Coronavirus Front-Runner
By Stephanie Baker
First data for Moderna Covid-19 vaccine show it spurs an immune response
By Matthew Herper & Damian Garde